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The debate regarding neurocognitive functions in the early stages of HIV infection is still
ongoing; different studies have reached contrasting conclusions, probably because many
of them take into account different cohorts of patients. A main distinction is between HIV
seropositive patients infected perinatally, and those infected postnatally. The aim of this
paper is to review results on neurocognitive dysfunctions and other types of neurological
involvement in a specific cohort of HIV+ patients infected postnatally: hemophilia patients.
Such a review is relevant, as HIV seropositive patients infected postnatally are understudied
with respect to patients infected perinatally, and as the results of the few studies aiming
at comparing them are contrasting. Taken together, the 11 studies reviewed suggest the
presence of both long-term neurocognitive dysfunctions and neurological alterations, such
as the presence of atrophic changes and lesions in the white matter. The current review
may offer new research insights into the neurocognitive dysfunctions in HIV-patients, and
on the nature of such dysfunctions.
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INTRODUCTION
HIV infection is associated with a variety of neurocognitive dys-
functions, which may occur at each stage of infection, and which
progress during the course of the illness, although such progres-
sion may vary depending on therapies. Before the introduction of
highly active antiretroviral therapy (HAART), neurocognitive dys-
functions represented a frequent outcome in about 60% of patients
(Reger et al., 2002; Ettenhofer et al., 2009). Since HAART became
current best practice, the quality of life of patients has improved,
and neurocognitive complications have been reduced (Reger et al.,
2002; Antinori et al., 2007). Notwithstanding, several studies have
highlighted difficulties in neurocognitive performance at differ-
ent levels (York et al., 2001; Sacktor et al., 2002; Carey et al.,
2006; Iudicello et al., 2008; Woods et al., 2008; Cattie et al., 2012;
Giesbrecht et al., 2014) in HIV seropositive (henceforth, HIV+)
patients; some authors have argued that such difficulties might
be more related to the presence of important covariates, such as
drug abuse, cranial traumas, and several psychological alterations
rather than to the direct action of HIV virus. The longitudinal
observation of these patients has given contrasting results: some
studies have not shown any decline in neurocognitive functions
(Selnes et al., 1990, 1992; Grassi et al., 1995) while others have
(Ayuso-Mateos et al., 2000; Woods et al., 2008; Ettenhofer et al.,
2009; Applebaum et al., 2010).
Although findings across the HIV literature are not entirely
consistent, a number of studies show that HIV-infected patients
present deficits in speed of information processing (Carey et al.,
2006; Giesbrecht et al., 2014), in fine motor speed (Sacktor
et al., 2002) in learning and memory (Carey et al., 2006; Maki
et al., 2009), in attention (Giesbrecht et al., 2014), and in mul-
tiple domains of executive functioning such as cognitive flex-
ibility, decision-making, and planning (Iudicello et al., 2008;
Cattie et al., 2012).
The issue of neurocognitive dysfunctions in HIV+ patients has
both a speculative and a social relevance. It is quite known that in
the US, for example, HIV+ patients have been victims of discrimi-
nation at work and/or at school because they have been considered
as disabled people with cognitive deficits (Harrison and McArthur,
1995).
In the last 10–15 years, a growing interest has developed in
the investigation of neurocognitive dysfunctions in specific HIV+
populations, such as homosexuals, drug-addicted people, and
hemophilic patients. The case of hemophilia is particularly inter-
esting even though the available studies are few and explorative.
Hemophilia is a genetically transmitted bleeding disorder that
affects mostly males, and requires infusions of clotting factors
derived from donors’ blood. Hemophilia may determine severe
bleeding episodes throughout life (Gringeri et al., 2011; Lessinger
et al., 2013) that cause progressive arthropathy and joint damage.
The major impact is on mobility, which may impair working and
social life (Riva et al., 2010). Particularly dangerous is the intracra-
nial bleeding, which can cause several neurocognitive dysfunc-
tions especially regarding coordination, gait, and motor function
(Mitchell et al., 1997; Basu et al., 2010). Hemophiliacs treated with
factor infusions before 1985 have been at risk of acquiring HIV
(Brookmeyer and Goedert, 1989). Several studies have shown that
about 60–80% of patients with hemophilia, exposed to infected
blood concentrates, contracted the HIV virus (Goedert, 1995).
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As a consequence, neurocognitive dysfunctions may also occur in
HIV+ hemophilia patients.
The interest in neurocognitive dysfunctions in hemophilia
HIV+ patients is quite innovative in the literature. Several studies
have been conducted on the neurodevelopmental effects of HIV
on children and adolescents who were infected perinatally, but
much less is known on individuals infected postnatally, as is the
case with hemophilia patients. This cohort of patients is different
for several reasons: children infected postnatally through trans-
fusion, have a more protracted course of disease than those who
were infected perinatally (Cohen et al., 1991; Loveland et al., 1994,
2000); furthermore, they usually lack several psycho-social risk fac-
tors, commonly associated with perinatal infection that may act
as confounding variables. Some such factors are, for instance, the
severe illness or death of a parent due to AIDS, or a lower socioe-
conomic status. Finally, the developmental course of postnatally
infected individuals may differ from that of those who are perina-
tally infected, because of differences in rate of brain growth: for
instance, Rubin et al. (1999) found different patterns of neurobe-
havioral development depending on age of infection, and Brouw-
ers et al. (1995) found differences in structural brain abnormalities
between perinatally and transfusion-infected children.
For all these reasons, the HIV+ hemophilia patient popula-
tion offers a unique opportunity to study the effects of postnatally
acquired HIV infection.
However, up to now, only a few studies have been conducted
on the neurocognitive dysfunctions of hemophilia HIV+ patients,
with conflicting results. Furthermore, most of these studies took
into account the influence of psycho-social issues such as health-
related quality of life (HrQoL) (e.g., Fischer et al., 2003), treatment
satisfaction (e.g., Gringeri et al., 2006; von Mackensen et al., 2013)
and caregivers’ burden (e.g., Dekoven et al., 2013), but did not take
into account the presence of HIV infection.
The present review examines works conducted in hemo-
philia patients HIV+ by systematically reviewing the literature
to describe neurocognitive dysfunctions and to describe similari-
ties and differences in comparison with the findings identified by
the mainstream medical literature on HIV.
We aim to: (i) review the neuropsychological studies in
HIV+ hemophilia patients performed so far; (ii) summarize the
opportunities and challenges for future studies in this context.
In the following sections, we briefly review the main findings in
this area. Studies were identified by searching the electronic data-
bases Ovid Medline (1979-present) and PubMed (1979-present)
and scanning reference lists of articles. Limits included the English
language and humans. The last search was run on March 1, 2014,
using the following search terms: HIV and hemophilia in combi-
nation with intellectual disabilities, behavioral disorders, intelli-
gence quotient (IQ), cognition, neuropsychological disorders, and
cognitive impairments.
RESULTS
The details of the major studies covered below are summarized in
Table 1.
Most of the 11 studies reviewed took into account children
and/or adolescents, and 2 evaluated adult patients. Most of the
studies are from the USA and Canada, with the exception of one
conducted in South Africa and two in Europe (UK and Germany).
The cognitive functions examined varied, and different types of
neuropsychological tests were used. However, the most important
abilities evaluated are attention, memory (verbal and spatial), and
motor skill coordination.
NEUROPSYCHOLOGICAL FINDINGS
As shown in Table 1, findings are often inconsistent and difficult
to summarize. The most atypical results are by Thompson et al.
(1996); a possible explanation may be that the comparison among
groups is affected by the different mean age of the three patient
groups (patients in the HIV-group were significantly older than
participants in the other two groups), and the neuropsychological
tests were not age-scaled.
Several of the remaining studies and most of the early research
findings on hemophilia and HIV are based on the Hemophilia
Growth and Development Study (HGDS; Hilgartner et al., 1993).
The HGDS was a multicenter study of the long-term effects of
HIV infection on growth and neurodevelopment in HIV+ hemo-
philiac children, most of whom were asymptomatic for HIV
disease at baseline, in comparison with a group of HIV− sub-
jects with hemophilia of similar age. Cross-sectional data from the
HGDS (Hilgartner et al., 1993; Loveland et al., 1994) and paral-
leled findings of contemporary studies (Whitt et al., 1993; Sirois
et al., 1998) have shown that the largely asymptomatic cohort of
HIV+ children and adolescents did not differ significantly from
HIV− hemophilic controls on a variety of neuropsychological
tests. However, as indicated in follow-up studies of HGDS patients
by Loveland et al. (2000) and Nichols et al. (2000), there was a sig-
nificant decline in neurocognitive functions over 5 years, directly
related to a decline in immune functioning. Furthermore, Watkins
et al. (2000), still within the framework of longitudinal results of
HGDS, has indicated that HIV-infected children showed signifi-
cant differences in sustained attention performance, as measured
by the Continuous Performance Test (CPT).
Both from HGDS results and from other cross-sectional stud-
ies (Whitt et al., 1993; Sirois et al., 1998), different authors have
concluded that the lower neuropsychological performance might
be attributed to the hemophilia itself and not to HIV. According
to these authors, children suffering from hemophilia have levels
of general mental ability, which are comparable with those of the
general population. However their decrease in specific cognitive
functions might be linked to the burden of illness that causes
arthropathy (motor speed coordination) or school absenteeism
for medical treatment (language and memory). These results are
in line with the recent review of Moser et al. (2013). Other
studies, on the contrary, have attributed the presence of neu-
rocognitive dysfunctions to the HIV+ condition. All such studies
have divided HIV+ hemophiliacs into sub-groups according to
patients’ immune functioning and the authors of such studies con-
cluded that significant differences in several cognitive functions
arise with the decrease of immunological functioning, and espe-
cially when the CD4+ cell counts≤200. For example, Riedel et al.
(1992) identified a linear association between the scarce neuropsy-
chological function in attention, motor skills, visual performance,
and the decrease of CD4+. Similarly, according to Blanchette et al.
(2002), HIV+ hemophiliacs have shown impairments in motor
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Table 1 | Listing of existing neuropsychological studies on hemophiliacs HIV+ patients.
Reference Country; type of participants Cognitive functions examined Major neurocognitive findings
Blanchette et al. (2002) Canada; cross-sectional study in children:
14 HIV+ and 11 HIV− hemophiliacs
IQ, language, visual memory, verbal
memory, motor speed, spatial memory,
fine motor skills
HIV+ hemophiliacs showed impairment in motor speed and fine motor
skills in comparison with HIV-patients
Hilgartner et al. (1993) USA; cross-sectional study in children and
adolescents. Three hundred thirty-three
patients aged 6–18: 207 HIV+
hemophiliacs and 126 HIV− hemophiliacs
(from HGDS)
IQ, memory, language, attention, visual
perception, spatial perception, fine motor
skills, emotional functioning
Around the 50% HIV+ hemophiliacs showed scores 1 SD below expected
levels in three functional areas in comparison with HIV− hemophiliacs: IQ,
language, memory
Loveland et al. (1994) USA; from HGDS: cross-sectional results IQ, memory, language, attention, visual
perception, spatial perception, fine motor
skills, emotional functioning
HIV+ hemophiliacs obtained lower results in comparison with HIV−
hemophiliacs in the following areas: non-verbal intelligence (IQ), spatial
perception, memory (non-verbal), language, decreasing is a linear
relationship with the decreasing of immune functioning
Loveland et al. (2000) USA; from HGDS: longitudinal results IQ, memory, language, attention, visual
perception, spatial perception, fine motor
skills
HIV+ hemophiliacs obtained lower results in comparison with HIV−
hemophiliacs in the following areas: non-verbal intelligence (IQ),
perception, memory (non-verbal), language, decreasing is a linear
relationship with the decreasing of immune functioning
Nichols et al. (2000) USA; from HGDS: longitudinal results Adaptive behavior style (including
communication skills), emotional
functioning
Decline in communication skills. Decreasing is a linear relationship with the
decreasing of immune functioning
Riedel et al. (1992) Germany; cross-sectional study in adults.
181 HIV+, and 28 HIV− hemophiliacs
Visual memory, motor speed, language,
attention
HIV+ hemophiliacs obtained lower results in comparison with HIV−
hemophiliacs in the following areas: attention, visuoperceptual speed,
visuomotor speed, memory (verbal), decreasing is a linear relationship with
the decreasing of immune functioning
Sirois et al. (1998) USA; cross-sectional study in children and
adolescents aged from 7 to 19: 178 HIV+
and 120 HIV− hemophiliacs
IQ, language, memory, attention, visual
memory, spatial perception, fine motor
skills, coordination, adaptive behavior
No differences between groups (lower performances of HIV+ are
associated with covariates such as academic problems, head trauma,
parents’ level of education)
Thompson et al. (1996) UK; cross-sectional study in adolescents:
31 HIV+, and 33 HIV− hemophiliacs plus
16 controls
IQ, motor skills, motor speed, language,
memory
HIV+ hemophiliacs performed better on most tests than HIV−
hemophiliacs
Turnbull et al. (1991) South Africa; case-study with four adults
HIV+ hemophiliacs
IQ, visual memory, spatial perception,
visual perception
HIV+ hemophiliacs obtained lower results in comparison with HIV−
hemophiliacs in higher mental functions
Watkins et al. (2000) USA; from HGDS: longitudinal results Attention Sustained attention was significant below in HIV+ hemophiliacs in
comparison with -patient independently from the levels of CD4+ cells
Whitt et al. (1993) USA; cross-sectional study in children and
adolescents: 25 HIV+ and 38 HIV−
hemophiliacs
IQ, attention, motor skills, visual
processing, language, memory
HIV+ hemophiliacs obtained lower results (1SD below) in comparison with
HIV− hemophiliacs in the following areas: attention, visuoperceptual
speed, visuomotor speed
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speed and fine motor skills, in comparison with those shown by
HIV− hemophiliacs. Similarly, Nichols et al. (2000) concluded
that HIV+ hemophiliacs present deficits in communication skills,
related to the immune functioning system.
MEDICAL NEUROLOGY AND NEUROIMAGING FINDINGS
The literature reported in Table 1, also gave us some interesting
findings regarding medical neurology and neuroimaging. Most
studies found neurological and neuroimaging tools to be essen-
tial in clinical diagnosis, useful in providing insights into the
pathogenesis of HIV infection of the central nervous system
(CNS), and in understanding the possible correlations with neu-
rocognitive functions. However, in the field of hemophilia, these
results are limited and heterogeneous. In terms of neurological
and neuroradiological aspects, Loveland et al. (2000) identified
neurologic abnormalities in HIV+ patients, such as progressive
encephalopathies related to the age of infection. Furthermore,
Sirois et al. (1998) identified a greater presence of decreased muscle
bulk (around 50%) in the HIV+ hemophiliacs. Regarding neu-
roimaging, Mitchell et al. (1997), Mitchell et al. (1993), and Sirois
et al. (1998) highlighted both the atrophic changes, as well as white
matter lesions in young hemophilia HIV+ patients detected by
magnetic resonance imaging (MRI).
Outside the HGDS context, two works deserve mention
(although not inserted in the table). Rahemtulla et al. (1986) evalu-
ating the clinical spectrum of the CNS in adult HIV+ patients with
hemophilia, described the presence of diffuse subacute encephali-
tis while Hoots et al. (1998) identified diffuse muscle atrophy on
neurological examination.
DISCUSSION
Taken together, the studies reviewed suggest some evidence in
common, although the issue is still explorative. Studies from dif-
ferent countries, including large cohorts as the HGDS, report a
long-term decline in neurocognitive functions in around 15–50%
of patients (Loveland et al., 1994; Sirois et al., 1998). Decline seems
to be proportional with the decrease of immunological function-
ing, especially when the CD4+ cell counts ≤200 (Riedel et al.,
1992; Nichols et al., 2000; Blanchette et al., 2002), even though
other studies have concluded that the decline is related to hemo-
philia per se (Hilgartner et al., 1993; Whitt et al., 1993; Loveland
et al., 1994; Sirois et al., 1998).
Discrepancies among HIV+ and HIV− groups were found
mainly in attention, memory performance, and visuomotor pro-
cessing. However, neuropsychological test batteries differ among
studies, in part because there is no agreement on what can be con-
sidered an abnormal test result (Schmälzle et al., 2011; Risko et al.,
2012).
Results show that the type of neurocognitive dysfunctions
in hemophilia HIV+ patients do not significantly differ from
other HIV cohorts with the exception of the executive func-
tioning’s domain, which appear to be unaltered in this group of
patients. However, the origin of such decline is not yet identified
unanimously and the debate is still open.
Summarizing, we may conclude that neuropsychological
assessment, neuroradiology examinations, and MRI of the
brain are important accessible tools in this clinical setting.
Neuropsychological examination has been more reliably used in
revealing the presence and character of neurocognitive dysfunc-
tions, while neurologic and neuroimaging studies have proved
helpful in identifying CNS tissue damage as a greater presence
of decreased muscle bulk and lesions in white matter, which may
become important markers in future research in the field.
FUTURE IMPLICATIONS
Given the current state of the art, more studies are warranted on
the mechanism behind the neurocognitive dysfunctions of HIV+
hemophiliacs: is it HIV-driven, or chronic immune-activation due
to other unknown conditions, or the hemophilia itself, that leads
to such a decline? The majority of the most recent studies seems to
confirm the first hypothesis, but several uncertainties still remain.
The clinical course of the neurocognitive dysfunctions is uniden-
tified. For instance, it might be the result of a process that has been
going on for years, or it might be the exitus of a subacute dete-
rioration in which viral control in the CNS is suddenly lost. As
reported by Schouten et al. (2011), we still do not know whether
such deterioration will strike each HIV-infected hemophiliac, or
a subset of patients at risk. Such a review can give us insight into
the literature and compare different results in different cohorts of
patients, but at the same time, many aspects about the neurology
system in these patients are an unknown. The few studies available
have provided information about the localization, the character,
and the magnitude of the disease present in neurocognitive dys-
functions but this information is still fragmented. Thus, so far
we are largely unable to elucidate and interconnect all the aspects
related to neurocognitive dysfunctions. However, the results of the
present review can be associated with those results identified in
the general population with HIV.
As the data collected are not homogeneous, it is necessary to
enhance the discussion around HIV and hemophilia from both
a cognitive and a psycho-social point of view. Indeed, studies are
still lacking on the impact of living with two chronic diseases,
where both the conditions have some similarities and represent
an evident burden on the patient’s life. As is well documented in
the literature, HIV and hemophilia have a very significant psycho-
social impact on patients, their families, and society in general,
including psychological, cognitive, emotional, and social effects.
These illnesses have important and durable effects on the individ-
ual, especially in the transition from adolescence where patients
need to address a number of adaptations, ranging from greater
demands for self-management of their health care, the impact of
their illness on their emerging sexuality and independence, and
the often difficult transition from familiar pediatric health care
settings to unfamiliar adult providers (e.g., Brown et al., 2000;
Pumariega et al., 2006; Steele et al., 2007; Bullinger and von Mack-
ensen, 2008; Riva et al., 2010; Schmälzle et al., 2011; Dekoven et al.,
2013; von Mackensen et al., 2013).
Today, the management of hemophilia has improved and
patients, at least in western countries, have at their disposal several
types of coagulation factor treatment and plasma-derivate con-
centrates. However, the geography of hemophilia is not the same
around the world and over 80% of the world’s hemophilia patients
receive inadequate or no therapy (Evatt et al., 1999; Kessler, 2005;
Young, 2012). In several countries, patients are still at risk of high
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mortality due to either hemophilia or HIV. Therefore, the present
review also aims to highlight hemophiliac patients’ conditions at
the center of society’s economic and ethical concerns, and of the
policy agenda.
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